<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02962011</url>
  </required_header>
  <id_info>
    <org_study_id>ZIVH</org_study_id>
    <nct_id>NCT02962011</nct_id>
  </id_info>
  <brief_title>Trial Comparing Barbed and Non-barbed Suture for Uterine Incision Closure at Cesarean Section</brief_title>
  <acronym>barbed</acronym>
  <official_title>Randomized Trial Comparing Barbed and Non-barbed Suture for Uterine Incision Closure at Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ziv Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ziv Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This was an unblinded randomized controlled trial. Women were randomized to uterine closure
      with the knotless barbed suture (Stratafix PDS, Ethicon) or Vicryl (Ethicon) at the time of
      elective cesarean. The primary outcome was closure time of the uterine incision. Also
      measured were blood loss during incision closure and the use of additional hemostatic
      sutures. Informed consent was obtained
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 1, 2016</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Actual">March 31, 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Knotless barbed suture vs conventional suture of uterine incision</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Uterine incision closure time</measure>
    <time_frame>5 months</time_frame>
    <description>uterine incision closure time</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>uterine incision blood loss</measure>
    <time_frame>5 months</time_frame>
    <description>uterine incision blood loss</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hemostatic suture use</measure>
    <time_frame>5 months</time_frame>
    <description>hemostatic suture use</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">102</enrollment>
  <condition>Cesarean Section</condition>
  <arm_group>
    <arm_group_label>Knotless barbed suture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>polyglactin 910</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vicryl</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Knotless barbed suture</intervention_name>
    <description>uterine incision closure</description>
    <arm_group_label>Knotless barbed suture</arm_group_label>
    <other_name>Stratafix</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>polyglactin 910</intervention_name>
    <description>uterine incision closure</description>
    <arm_group_label>polyglactin 910</arm_group_label>
    <other_name>Vicryl</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective cesarean

          -  elective repeat cesarean

        Exclusion Criteria:

          -  emergent or urgent cesarean

          -  PROM

          -  chorioamninitis

          -  placental abruption

          -  placenta previa or accreta

          -  known uterine fibroids

          -  women with known medical problems such as coagulopathy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Peleg</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ziv Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ziv Medical Center</name>
      <address>
        <city>Zefat</city>
        <zip>13100</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 9, 2016</study_first_submitted>
  <study_first_submitted_qc>November 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2016</study_first_posted>
  <last_update_submitted>April 13, 2017</last_update_submitted>
  <last_update_submitted_qc>April 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ziv Hospital</investigator_affiliation>
    <investigator_full_name>David Peleg</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Cesarean, incision, suture,</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Surgical Wound</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

